PROM1

protein-coding

prominin 1, the group of CD molecules

Gene summary

This gene encodes a pentaspan transmembrane glycoprotein. The protein localizes to membrane protrusions and is often expressed on adult stem cells, where it is thought to function in maintaining stem cell properties by suppressing differentiation. Mutations in this gene have been shown to result in retinitis pigmentosa and Stargardt disease. Expression of this gene is also associated with several types of cancer. This gene is expressed from at least five alternative promoters that are expressed in a tissue-dependent manner. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]

Previous symbols:
  • PROML1
  • MCDR2
  • STGD4

MANE transcript

NM_006017.3

Inheritance

AD, AR

ClinVar variants

P:188U:567B:206

Top phenotype

Cone-rod dystrophy 12; Macular dystrophy, retinal, 2; Stargardt disease 4; Retinitis pigmentosa 41

gnomAD constraint

pLI —, LoF o/e 0.8

Max pathogenic AF

—

Genomic locus

chr4:15,963,076-16,084,378

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~121.3 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

Stargardt diseaseSUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0019353

Submitter: Orphanet

retinitis pigmentosa 41DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0012796

Submitter: G2P

retinitis pigmentosaSUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0019200

Submitter: Orphanet

cone-rod dystrophySUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0015993

Submitter: Orphanet

PROM1-related dominant retinopathySTRONG

Inheritance Pattern: AD

Disease ID:MONDO:1040053

Submitter: PanelApp Australia

PROM1-related dominant retinopathyDEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:1040053

Submitter: ClinGen

The *PROM1* gene was first reported in relation to autosomal dominant retinal degeneration in 2008 (PMID: 18654668). The phenotypic spectrum includes the following clinical diagnoses: STGD4 (Stargardt Disease-4) characterized by macular dystrophy, yellow fundus flecks, and dark choroid pattern (PMID: 10420191); autosomal dominant MCDR2 (retinal macular dystophy-2 ) characterized by retinal pigment epithelium atrophy, bull's-eye macular dystrophy, visual impairment, central scotomata, and age-related rod and cone abnormalities (PMID: 12657606); autosomal dominant cone-rod dystrophy characterized by both cone and rod photoreceptor degeneration (PMID: 18654668). Per criteria outlined by the ClinGen Lumping & Splitting Working Group, dominant cases were compared with cases of PROM1-related recessive retinopathy, which includes cone-rod dystrophy 12 and retinitis pigmentosa 41. The recessive disease is more severe with earlier onset, and is associated with null or close to null PROM1 function. The dominant disease is associated with milder phenotypes, and has a late adulthood age onset. It is associated with missense variants and thought to arise via a dominant negative mechanism. Due to the distinct underlying molecular mechanisms of the two disease forms, dominant cases were split from the recessive cases and were collectively curated under PROM1-related dominant retinopathy. Four suspected disease-causing missense variants were scored as part of this curation, which have been collectively reported in twelve probands in nine publications (PMID: 18654668, PMID: 10205271, PMID: 12657606, PMID: 38072963, PMID: 20393116, PMID: 28840994, PMID: 31576780, PMID: 29416601, PMID: 28095140). All except three probands harbor the p.Arg373Cys variant. Three large families with distinct disease haplotypes showed strong evidence of co-segregation of the genotype with affected status (PMID: 18654668). The literature included more case-level and co-segregation evidence, but its inclusion in this curation was not necessary to reach the maximum score for genetic evidence. This gene-disease association is also supported by experimental evidence indicating that degeneration of the photoreceptor layer may be the shared defect underlying PROM1-related disease. *PROM1* is specifically expressed in retinal tissues (PMID: 30239781) and the protein product localizes particularly to the discs at the base of the photoreceptor cell outer segments (PMID: 18654668, PMID: 10587575). This localization is consistent with the known association of PROM1 with membrane protrusions (PMID: 10681530) and its proposed function in cell membrane homeostasis by regulating formation of extracellular vesicles (PMID: 39168849). PROM1 is an integral membrane protein that associates with cholesterol, and mutations in cholesterol binding domains affect membrane homeostasis in cultured mammalian cells. The cadherin family member CDHR1 gene product co-immunoprecipitates with PROM1 (PMID: 18654668), and harbors variants associated with cone-rod dystrophy 15 (PMID: 20805371), retinal macular dystrophy (PMID: 28765526), and retinitis pigmentosa 65 (PMID: 20087419). A transgenic mouse expressing the dominant PROM1 p.Arg373Cys variant showed similar phenotypes observed in human STGD4 and MCDR2 cases; the mutant mouse retina showed disorganized outer segment disc membranes and mislocalized PROM1, supporting the role of PROM1 in membrane organization in photoreceptors. In summary, *PROM1* is definitively associated with PROM1-related dominant retinopathy. This has been demonstrated in both research and diagnostic settings, and has been upheld over time without the emergence of contradictory evidence, leading to a Definitive classification. This classification was approved by the ClinGen Retina Gene Curation Expert Panel on October 3rd, 2024 (SOP Version 10).

retinitis pigmentosa 41STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0012796

Submitter: PanelApp Australia

retinal macular dystrophy type 2DEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0011957

Submitter: G2P

PROM1-related recessive retinopathyDEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:1040052

Submitter: ClinGen

The *PROM1* gene was first reported in relation to autosomal recessive retinal degeneration in 2000 (PMID: 10587575). Subsequent publications expanded the phenotypic spectrum associated with homozygous or compound heterozygous *PROM1* variants to include diverse diagnoses such as retinitis pigmentosa 41 (PMID: 17605048) and cone-rod dystrophy 12 (PMID: 24474277). These cases typically have onset in childhood or adolescence and exhibit a wide variety of retinal features ranging from macular degeneration, progressive reduction in visual acuity, and central scotoma to night blindness, peripheral visual field loss, retinal blood vessel attenuation, and optic disc pallor. Electroretinogram responses are generally decreased in amplitude or undetectable, particularly from cones. Degeneration of the retinal pigment epithelium in the macula is often observed and may be described as bull’s eye maculopathy. Optical coherence tomography images generally show retinal thinning and particularly loss of the photoreceptor layer. The spectrum of disease also includes cases with heterozygous *PROM1* variants diagnosed as cone-rod dystrophy 12 (PMID: 35947379), Stargardt-like macular dystrophy (PMID: 29416601), or retinal macular dystrophy type 2 (PMID: 18654668). These heterozygous cases exhibit relatively later onset but a similar range of phenotypes that can include reduced visual acuity, bull's-eye macular dystrophy, progressive macular atrophy, color vision abnormalities, and night blindness. Per criteria outlined by the ClinGen Lumping & Splitting Working Group, recessive cases of cone-rod dystrophy or retinitis pigmentosa were compared with dominant cases of cone-rod dystrophy, retinal macular dystrophy, or Stargardt-like maculopathy. The shared mode of inheritance, molecular mechanism (biallelic loss-of-function) and phenotypic overlap among recessive cases motivated cone-rod dystrophy 12 and retinitis pigmentosa 41 to be combined into a single gene curation, with the lumped disease entity referred to as PROM1-related recessive retinopathy. On the other hand, cases with overlapping phenotypes but a dominant mode of inheritance differed in their molecular mechanism (dominant negative), whereas the recessive families had unaffected heterozygous carriers. Therefore, dominant cases have been lumped into a separate disease entity, referred to as PROM1-related dominant retinopathy. Eight suspected disease-causing variants were scored as part of this curation (three nonsense, three frameshift, one canonical splice site variant, and one non-canonical intronic variant disrupting splicing), which have been collectively reported in six probands in six publications (PMID: 10587575, PMID: 17605048, PMID: 24474277, PMID: 24763286, PMID: 25472526, PMID: 26702251). Four of the probands scored in this curation harbored the variant in the homozygous state, with three reported as consanguineous, while two other probands harbored variants in compound heterozygosity. Two large families with evidence of co-segregation of the genotype with affected status contributed to the scoring of the gene-disease relationship (PMID: 10587575, PMID: 17605048). The literature included more case-level and co-segregation evidence, but its inclusion in this curation was not necessary to reach the maximum score for genetic evidence. This gene-disease association is also supported by experimental evidence indicating that degeneration of the photoreceptor layer may be the shared defect underlying *PROM1*-related recessive disease. *PROM1* is specifically expressed in retinal tissues (PMID: 30239781) and the protein product localizes particularly to the discs at the base of the photoreceptor cell outer segments (PMID: 10587575, PMID: 18654668). This localization is consistent with the known association of PROM1 with membrane protrusions in general (PMID: 10681530) and its proposed function as an organizer of cell membrane topology in the morphogenesis of the developing photoreceptor cell outer segment disc membrane. The CDHR1 gene product similarly localizes to these structures, co-immunoprecipitates with PROM1 (PMID: 18654668), and harbors variants associated with cone-rod dystrophy 15 (PMID: 20805371), retinal macular dystrophy (PMID: 28765526), and retinitis pigmentosa 65 (PMID: 20087419). Homozygous knockout of the mouse ortholog *Prom1* results in light-dependent degeneration of the photoreceptor and outer nuclear layers, and defective dark-adapted electroretinogram responses (PMID: 25414197). Homozygous deletion of the zebrafish ortholog *Prom1b* results in photoreceptor degeneration, enhanced apoptosis, loss of the outer nuclear layer, and delayed morphogenesis of outer segment discs (PMID: 31362982). In summary, *PROM1* is definitively associated with PROM1-related recessive retinopathy. This has been repeatedly demonstrated in both research and diagnostic settings, and has been upheld over time without the emergence of contradictory evidence, leading to a Definitive classification. This classification was approved by the ClinGen Retina Gene Curation Expert Panel on April 4th, 2024 (SOP Version 10).

retinitis pigmentosa 41STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0012796

Submitter: Labcorp Genetics (formerly Invitae)

retinal macular dystrophy type 2STRONG

Inheritance Pattern: AD

Disease ID:MONDO:0011957

Submitter: Labcorp Genetics (formerly Invitae)

cone-rod dystrophy 12STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0012983

Submitter: Labcorp Genetics (formerly Invitae)

Clinical Genomic Database (CGD)

Cone-rod dystrophy 12; Macular dystrophy, retinal, 2; Stargardt disease 4; Retinitis pigmentosa 41AD/AR

Manifestation: Ophthalmologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 10205271; 10587575; 12657606; 17605048; 18654668; 20393116; 20859302; 24474277; 26702251; 29416601; 31576780Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to PROM1 variants in ClinVar

23 Conditions Cataloged
not providedTotal: 1026
PROM1-related disorderTotal: 205
Inborn genetic diseasesTotal: 153
not specifiedTotal: 136
Cone-rod dystrophy 12Total: 115
Retinal dystrophyTotal: 114
Retinal macular dystrophy type 2Total: 101
Stargardt disease 4Total: 99

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_006017.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
20
clinvar
154
clinvar
3
clinvar
178
missense
1
clinvar
15
clinvar
536
clinvar
48
clinvar
1
clinvar
601
nonsense
32
clinvar
20
clinvar
3
clinvar
55
start loss
2
clinvar
2
frameshift
37
clinvar
27
clinvar
1
clinvar
65
splice donor/acceptor (+/-2bp)
18
clinvar
35
clinvar
7
clinvar
60
Total90985672024961

Highest pathogenic variant AF is 0.00033118948

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 97 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_006017.3RefSeqNP_006008.126MANE Select
ENST00000447510.7EnsemblENSP00000415481.226MANE Select
NM_001145847.2RefSeqNP_001139319.125Standard
NM_001145848.2RefSeqNP_001139320.125Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Transcriptional misregulation in cancer - Homo sapiens (human)
  • Extracellular vesicle-mediated signaling in recipient cells

Biological Process

  • retina layer formation
  • photoreceptor cell maintenance
  • retina morphogenesis in camera-type eye
  • camera-type eye photoreceptor cell differentiation
  • glomerular visceral epithelial cell differentiation

Molecular Function

  • protein binding
  • cholesterol binding
  • actinin binding
  • cadherin binding

Cellular Component

  • photoreceptor outer segment
  • extracellular space
  • endoplasmic reticulum
  • endoplasmic reticulum-Golgi intermediate compartment
  • plasma membrane

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000510224
Coding exons
26
Length
121303
Individuals with no LoFs
124483
Homozygous LoFs
0
Heterozygous LoFs
176
Defined
124659
p
0.000706
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense-0.6134784421.080.00002325627
Missense (PolyPhen)150147.21.0192005
Synonymous0.1111681700.9890.000009641621
Loss of Function1.263948.50.8050.00000245629

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000140.00013rare
Latino/Admixed American0.00110.0011notable
Ashkenazi Jewish0.0000990.000099rare
East Asian0.000670.00067rare
Finnish0.000240.00023rare
European (Non-Finnish)0.000940.00092rare
South Asian0.000300.00029rare
Other0.000830.00083rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: May play a role in cell differentiation, proliferation and apoptosis (PubMed:24556617). Binds cholesterol in cholesterol- containing plasma membrane microdomains and may play a role in the organization of the apical plasma membrane in epithelial cells. During early retinal development acts as a key regulator of disk morphogenesis. Involved in regulation of MAPK and Akt signaling pathways. In neuroblastoma cells suppresses cell differentiation such as neurite outgrowth in a RET-dependent manner (PubMed:20818439). {ECO:0000269|PubMed:20818439, ECO:0000269|PubMed:24556617}.;
Disease
DISEASE: Retinitis pigmentosa 41 (RP41) [MIM:612095]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:10587575, ECO:0000269|PubMed:17605048}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cone-rod dystrophy 12 (CORD12) [MIM:612657]: An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors. {ECO:0000269|PubMed:18654668}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Stargardt disease 4 (STGD4) [MIM:603786]: A common hereditary macular degeneration. It is characterized by decreased central vision, atrophy of the macula and underlying retinal pigment epithelium, and frequent presence of prominent flecks in the posterior pole of the retina. {ECO:0000269|PubMed:18654668}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Retinal macular dystrophy 2 (MCDR2) [MIM:608051]: A bull's-eye macular dystrophy characterized by bilateral annular atrophy of retinal pigment epithelium at the macula. {ECO:0000269|PubMed:18654668}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.315

Intolerance Scores

RVIS EVS
-1.37
RVIS percentile EVS
4.48

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.739

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.